Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-29

Clinical Trial Update: Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome [NA]

View source ↗

Summary

This clinical trial update describes a study investigating triggers and risk factors for developing reversible cerebral vasoconstriction syndrome. The trial is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Reversible Cerebral Vasoconstriction Syndrome | NA | Status: RECRUITING